scholarly journals 135P The real-world use of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor mutated (EGFRm) advanced (stage IIIb/IIIc/IV) non-small cell lung cancer (NSCLC) patients

2021 ◽  
Vol 16 (4) ◽  
pp. S770-S771
Author(s):  
J. Subramanian ◽  
Y-L. Choi ◽  
T-Y. Chou ◽  
J. Gregg ◽  
R. Hui ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document